Mayne Pharma Do Brasil Ltda
NDC Database

Mayne Pharma Do Brasil Ltda

NDC Database

National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.

Drug for Further Processing
  • Total Records 6
  • Latest Marketing Date 2019-05-20
  • Data Source FDA
  • First Marketing Date 2013-07-29
Company Overview

Company

Mayne Pharma Do Brasil Ltda

Country

Brazil

Website

Visit Website

Email

Social Profiles

Company Snapshot

Mayne Pharma Do Brasil Ltda

Rua Guilherme de Almeida 70 Recreio dos Bandeirantes Recreio, RJ 22790-100

Brazil

www.libbs.com.br/ View on Map
NDC Records ( 6 records )
2018
09 Mar
Drug for Further Processing NDC: 50546-077

Nonproprietary Name

Carbidopa and Levodopa

Dosage Form

TABLET

Strength

10; 100 mg/1; mg/1

Labeler

Mayne Pharma International Pty Ltd

Marketing Category

DRUG FOR FURTHER PROCESSING

50546-077

Substance

CARBIDOPA; LEVODOPA

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2018-03-09

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2013
29 Jul
Drug for Further Processing NDC: 50546-250

Nonproprietary Name

erythromycin

Dosage Form

CAPSULE, DELAYED RELEASE PELLETS

Strength

250 mg/1

Labeler

Mayne Pharma International Pty Ltd

Marketing Category

DRUG FOR FURTHER PROCESSING

50546-250

Substance

ERYTHROMYCIN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2013-07-29

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2018
26 Oct
Drug for Further Processing NDC: 50546-462

Nonproprietary Name

Itraconazole

Dosage Form

CAPSULE, GELATIN COATED

Strength

65 mg/1

Labeler

Mayne Pharma International Pty Ltd

Marketing Category

DRUG FOR FURTHER PROCESSING

50546-462

Substance

ITRACONAZOLE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2018-10-26

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2019
20 May
Drug for Further Processing NDC: 50546-580

Nonproprietary Name

Budesonide

Dosage Form

CAPSULE, DELAYED RELEASE PELLETS

Strength

3 mg/1

Labeler

Mayne Pharma International Pty Ltd

Marketing Category

DRUG FOR FURTHER PROCESSING

50546-580

Substance

BUDESONIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2019-05-20

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2018
09 Mar
Drug for Further Processing NDC: 50546-856

Nonproprietary Name

Carbidopa and Levodopa

Dosage Form

TABLET

Strength

25; 100 mg/1; mg/1

Labeler

Mayne Pharma International Pty Ltd

Marketing Category

DRUG FOR FURTHER PROCESSING

50546-856

Substance

CARBIDOPA; LEVODOPA

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2018-03-09

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2018
09 Mar
Drug for Further Processing NDC: 50546-858

Nonproprietary Name

Carbidopa and Levodopa

Dosage Form

TABLET

Strength

25; 250 mg/1; mg/1

Labeler

Mayne Pharma International Pty Ltd

Marketing Category

DRUG FOR FURTHER PROCESSING

50546-858

Substance

CARBIDOPA; LEVODOPA

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2018-03-09

End Marketing Date

-

Listing Record Certified Through

2027-12-31

Related Databases
  • FDA Inspections
    6 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    6 View
  • FDA Approved Drugs Database
    0 View
  • Drug Prices in Switzerland
    0 View
NDC Type Breakdown
6 total
  • Drug for Further Processing
Official Source

NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).

Visit FDA NDC Directory
NDC Record Details Preview

Explore important National Drug Code information available in the records above.

NDC

50546-077

Nonproprietary Name

Carbidopa and Levodopa

Labeler

Mayne Pharma International Pty Ltd

Dosage Form

TABLET

FDA NDC Data

National Drug Code information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized NDC records

NDC data is based on publicly available U.S. Food and Drug Administration (FDA) National Drug Code information.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit